2nd Annual Biocompatibility Testing, Material Safety & Contaminant Control for Medical Devices 2026 Conference
- 01-02 October 2026
CLIN-r+ are delighted to announce their participation at the 2nd Annual Biocompatibility Testing, Material Safety & Contaminant Control for Medical Devices 2026 Conference.
Our Director of Clinical and Regulatory Affairs, Jacqueline van Druten will be discussing Standards in Motion: FDA/EU audit Trends in Reviewing Devices Under the New ISO 10993-1 and ISO 18562 Updates. Fresh perspective on practical implications, evidence requirements, and audit expectations.
Date 01 October 2026 | Time: 10:10 -10:50am | Duration 20min and 10min Q&A
Available in person and online.
Our Clinical & Regulatory Affairs Director will deliver a timely and practical update on how regulators are applying the newly released ISO 10993-1:2025 and ISO 18562-1:2024 standards in real-world submissions. Drawing from recent FDA feedback and EU MDR review experience, this session will unpack emerging audit trends, evidence expectations, and common gaps being identified in respiratory and gas pathway devices. Attendees will gain first-hand insight into how benefit-risk is being interpreted, what regulators are prioritising post-update, and how to proactively align biological evaluation strategies to avoid delays and findings.
It is with great excitement that we invite you to the 2nd Annual Biocompatibility Testing, Material Safety & Contaminant Control for Medical Devices Conference 2026—a highly anticipated gathering of industry leaders, innovators, and experts dedicated to advancing patient safety and regulatory excellence.
Building on the strong success of our inaugural event, this year’s conference brings together a global community of professionals from medical device manufacturers, regulatory bodies, testing laboratories, and materials science to address the evolving challenges of biocompatibility, material safety, and contaminant control. Over the course of the event, you will explore the latest regulatory expectations, scientific advancements, risk mitigation strategies, and real-world case studies shaping the future of medical device development.
This conference is designed to foster meaningful dialogue, practical learning, and valuable connections—empowering attendees to navigate complexity, ensure compliance, and drive innovation with confidence.
We are honored to welcome you and look forward to an engaging, insightful, and collaborative experience.
MORE INFO ON THE CONFERENCE: